Effect Of Ramadhan Fasting On Apolipoprotein B And Small Dense Ldl In Type 2 Diabetes Mellitus Patients


  • Joseph Partogi Sibarani Department of Internal Medicine, Faculty of Medicine, Universitas HKBP Nommensen


Ramadan fasting, apolipoprotein B and small dense LDL.


This study's objective was to ascertain how type 2 Diabetes Mellitus patients' apolipoprotein B and small dense LDL were affected by Ramadan fasting. On 19 patients who had been diagnosed with type 2 DM at H. Adam Malik General Hospital Medan, a longitudinal prospective study from the fasting month of Ramadan until the end of the 2015 Ramadan fast was employed as the research methodology. The information was gathered by obtaining blood samples at the start and end of the Ramadan fast, after which the levels of apolipoprotein B and small dense LDL were determined. The T-Test and Wilcoxon tests were then used to assess the data. According to the study's findings, 13 respondents (68.4%) of the 19 patients with type 2 diabetes were men, and their average age was 57.26 years. Apoliprotein B (p=0.0001), small dense LDL (p=0.022), 2-hour PPG DGD (p=0.039), and mean body weight (p0.001) all indicated statistically significant changes. According to the study's findings, type 2 DM patients' apolipoprotein B and small dense LDL are significantly affected by Ramadan fasting.


Jaleel MA, Raza SA, Farah Naaz Fathima FN, Jaleel BNF. Ramadan and diabetes: As-Saum (The fasting):

Indian J Endocrinol Metab. 2011 Oct-Dec; 15(4): 268–273

Azizi F,Siahkolah B. Ramadan Fasting and Diabetes Mellitus:Int J Ramadan Fasting Res.1998;2:8-17.

Azizi F (2002) Research in islamic fasting and health.Ann Saudi med 22:186-191

Kamal S, Ahmad QS, Sayedda K, Haque M.Effect of islamic fasting on lipid profile, total protein and albumin

on healthy muslim male subjects of shri ram murti smarak institute of medical sciences, bareilly, uttar

Pradesh:National Journal of medical research.2012 Oct-Dec;2(4):407-410

Alzoghaibi MA, Pandi-Perumal SR, Sharif MM, Bahammam AS.Diurnal Intermittent Fasting during Ramadan:

The Effects on Leptin and Ghrelin Levels: Plos One.2014 maret;9(3):1-7

Sniderman AD, Furberg CD, Keech A et al. Apolipoproteins versus lipids as indices of coronary risk and as

targets for statin treatment. Lancet 2003; 361: 777–80.

Ahmed Adlounia, Noreddine Ghalimb, Rachid Saı¨ lea, Nezha Hdab, Henri-Joseph Parrac, Abdellah

Benslimaneb, Beneficial effect on serum apo AI, apo B and Lp AI levels of Ramadan fasting, Clinica Chimica

Acta Volume 271, Issue 2, 23 March 1998, Pages 179–189

International Journal of Health and Pharmaceutical


Sh.Yarahmadi, B.Larijani, M.H.Bastanhagh, M. Pajouhi, R.Baradar Jalili, F. Zahedi, etal., Metabolic and clinical

effects of Ramadan fasting in patients with type II diabetes, J. Coll. Physicians Surg. Pak. 13 (2003) 329–332.

Khaled BM, Bendahmane M, Belbraouet S. Ramadan fasting induces modifications of certain serum

components in obese women with type 2 diabetes:Saudi Med J.2006;27(1):23-26

Saasa DA, Attou S, Moutadi F, Kassoul S, Italhi M, Kati D. Effect of the Ramadan on the variations of certain

anthropometric and biochemical parameters in type 2diabtec patients treated with medicationsmixture

(biguanides and sulfamides): Advances in Biological Research.2008;2(5-6):111-120

Al-Kirwi INS. Effect of Ramadan fasting on metabolic parameters of type 2 diabetic patients: Iraqi


Fararjeh MA, Aljamal A, Faris Mo’ez Al-Islam E, Al-Kurd RA, Khalil M, Al-Bustanji Y. Effect of intermittent

fasting on lipid profile and hematological parameters in healthy volunteers in Jordan: Universal Journal of

Medicine and Dentistry.2012;1(10) januari:005-006.

Khafaji HARH, Bener A, Osman M, Al Merri A, Al Suwaidi J. The impact of diurnal fasting during Ramadan

on the lipid profile, hs-CRP, and serum leptin in stable cardiac patients: Vascular Health and Risk


Shehab A, abdulle A, El Issa A, al Suwaidi J, Nagelkerke N. Favorable changes in lipid profile: the effects of

fasting after Ramadan: Plos One.2012 oktober;8(10):e47615;1-4.

Perkumpulan Endokrinologi Indonesia.Konsensus pengelolaan dan pencegahan diabetes mellitus tipe 2 di

Indonesia 2011

American Diabetes Association. Standards of Medical Care in Diabetes 2013

Kaku K. Pathophysiology of type 2 diabetes and its treatment policy: JMAJ.2010 53(1): 41–46

Chen J, Wildman RP, Hamm LL, Muntner P, Reynolds K, Whelton PK, He J: Third National Health and

Nutrition Examination Survey. Association between inflammation and IR in U.S. nondiabetic adults: results

from the Third National Health and Nutrition Examination Survey. Diabetes Care 2004, 27:2960–2965.

Eckel RH, Kahn R, Robertson RM, Rizza RA: Preventing cardiovascular disease and diabetes: a call for action

from the American Diabetes Association and the American Heart Association. Circulation 2006,113:2943–2946.

Turner RC, Holman RR, Matthews D, Hockaday TD, Peto J (1979). "Insulin deficiency and insulin resistance

interaction in diabetes:estimation of their relative contribution by feedback analysis from basal plasma insulin

and glucose concentrations.". Metabolism 28 (11):1086–96. doi:10.1016/0026-0495(79)90146- X.PMID 386029.

Méghit Boumédiène Khaled and Slimane Belbraouet, Ramadan Fasting Diet Entailed a Lipid Metabolic

Disorder Among Type 2 Diabetic Obese Women Department of Biology, Faculty of Sciences, Djillali Liabès

University, Sidi-bel-Abbes, Algeria

Mohsen Nematy, Maryam Alinezhad-Namaghi, Masoud Mahdavi Rashed, Mostafa Mozhdehifard, Seyedeh

Sania Sajjadi, Saeed Akhlaghi, Maryam Sabery, Seyed Amir R Mohajeri, Neda Shalaey, Mohsen Moohebat and

Abdolreza Norouz, Effects of Ramadan fasting on cardiovascular risk factors: a prospective observational study,

School of Nutrition, Canada, University of Moncton, Moncton, E1A 3E9 Nutrition Journal 2012, 11:69.

G.WALLDIUS&I.JUNGNER,Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease

and targets for lipid-modifying therapy From the King Gustaf V Research Institute and Karolinska Institute,

Stockholm; and AstraZeneca, Mo¨lndal; and CALAB Research and Unit of Clinical Epidemiology, Karolinska

Hospital and Karolinska Institute, Stockholm;Sweden, Journal of Internal Medicine 2004; 255:188–205

Seth S. Martin, Atif N. Qasim, Nehal N. Mehta, Megan Wolfe, Karen Terembula, Stanley Schwartz, Nayyar

Iqbal, Mark Schutta, Roshanak Bagheri, and Muredach P. Reilly, Apolipoprotein B but not LDL Cholesterol Is

Associated With Coronary Artery Calcification in Type 2 Diabetic Whites, DIABETES,VOL.58,AUGUST 2009

Campos H, Arnold KS, Balestra ME, Innerarity TL, Krauss RM: Differences in receptor binding of LDL

subfractions. Arterioscler Thromb16:794–801, 1996

Bjornheden T, Babyi A, Bondjers G, Wiklund O: Accumulation of lipoprotein fractions and subfractions in the

arterial wall, determined in an in vitro perfusion system. Atherosclerosis 123:43–56, 1996

Anber V, Griffin BA, McConnell M, Packard CJ, Shepherd J: Influence of plasma lipid and LDL-subfraction

profile on the interaction between low density lipoprotein with human arterial wall

proteoglycans.Atherosclerosis 124:261–271, 1996

Chait A, Brazg RL, Tribble DL, Krauss RM: Susceptibility of small, dense, low-density lipoproteins to oxidative

modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med 94:350–356,1993

Moeliandari F. Small dense LDL pada familial combined Hyperlipidemia dan penyakit kardiovaskuler,

Informasi Laboratorium Prodia, 2003; No 6: 4–5.

International Journal of Health and Pharmaceutical


Jaleel, M. A., Raza, S. A., Fathima, F. N., & Jaleel, B. N. F. (2011). Ramadan and diabetes: As-Saum (The

fasting). Indian Journal of Endocrinology and Metabolism, 15(4), 268–73. doi:10.4103/2230-8210.85578

Lamarche B,Tchernof A,Moorjani S.Small dense low density lipoprotein particles as a predictor of the risk of

ischemic heart disease in men:prospective results from the Quebec cardiovascular study.Circulation1997: 69–75.

Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman

MJ, Durrington P, Erdine S, Halcox J, Hobbs R, JKjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D for

The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the

European Atherosclerosis Society (EAS). ESC/EAS Guidelines for the management of dyslipidaemias. Eur

Heart J 2011;32:1769-818.

Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB. Non–high-density lipoprotein cholesterol

and apolipoprotein B in the prediction of coronary heart disease in men. Circulation 2005;112:3375-83.

Ridker P M, Rifai N, Cook NR, Bradwin G, Buring JE. Non-HDL cholesterol, apolipoproteins A-I and B100,

standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA


EI hazmi MAF, AI-Faleh FZ; Effects of Ramadan fasting in the values of haematological and biochemical

parameters. Saudi Med J, 1987; 8:171- 178.




How to Cite

Partogi Sibarani, J. (2023). Effect Of Ramadhan Fasting On Apolipoprotein B And Small Dense Ldl In Type 2 Diabetes Mellitus Patients. International Journal of Health and Pharmaceutical (IJHP), 3(4), 877–883. Retrieved from https://ijhp.net/index.php/IJHP/article/view/289